Cyrus Harmon Sells 5,000 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Stock

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]

Related Keywords

Cyrus Harmon ,Clarivest Asset Management ,Silverarc Capital Management ,Goldman Sachs Group ,Olema Pharmaceuticals ,Quarter For Olema Pharmaceuticals ,Victory Capital Management Inc ,News Ratings For Olema Pharmaceuticals Daily ,Nasdaq ,Vivo Capital ,Olema Pharmaceuticals Inc ,Institutional Investors Weigh In On Olema Pharmaceuticals ,Olema Pharmaceuticals Trading ,Get Free Report ,Director Cyrus Harmon ,Capital Management ,Vest Asset Management ,One Financial ,Olema Pharmaceuticals Daily ,